Abstract

Background: A recent ongoing pandemic of coronavirus disease named coronavirus disease 2019 (COVID-19) has spread in Syria from March 2020 with a pattern of a slow case increase. So far, the government has put the country under lock-down orders as a preventive measure. However, there is a considerable belief in the medical community of our country supposes that the virus has previously passed through the country depending on the high numbers of diagnosed severe respiratory infections early in 2020. Thus, this study was designed to determine the number of people with detectable antibodies to SARS-CoV-2 from two samples of healthy adults with and without a previous history of severe respiratory infection in the last 6 months of the study. Materials and Methods: To this end, samples were collected from 123 and 198 subjects with a previous severe respiratory infection and healthy controls, respectively. Then, immunoglobulin M (IgM) and IgG anti-SARS-CoV-2 antibodies were tested as well. Results: None of the samples from both groups tested IgG positive in the assay while four tested IgM samples were positive. Accordingly, these positive samples were re-analyzed and remained IgM positive in the second test although the reverse transcriptase-polymerase chain reaction for the SARS-CoV-2 virus was negative. Conclusion: Based on our findings, there is no evidence concerning the previous COVID-19 infection in Syria thus it is suggested that all isolation and lock-down orders should be respected as an effective preventive tool in this regard.

Highlights

  • According to Adhikari et al [1], coronavirus disease 2019 (COVID-19) is a newly described syndrome labeled with a severe acute respiratory disease caused by coronavirus 2 (SARS-CoV-2)

  • An ongoing pandemic of COVID-19 has spread to Syria since March 2020, when the first confirmed case has been announced in Damascus on 22 March

  • Given the above-mentioned explanations, the current study aimed to evaluate the concept of previous exposure to the SARS-CoV-2 virus in Syria

Read more

Summary

Introduction

According to Adhikari et al [1], coronavirus disease 2019 (COVID-19) is a newly described syndrome labeled with a severe acute respiratory disease caused by coronavirus 2 (SARS-CoV-2). The virus was recognized as the cause of the Wuhan pneumonia outbreak in December 2019 in China [2] It has rapidly spread causing a pandemic within three months from the first case detection in China reaching outbreaks in widely spaced countries in South America and Europe [3]. A recent ongoing pandemic of coronavirus disease named coronavirus disease 2019 (COVID-19) has spread in Syria from March 2020 with a pattern of a slow case increase. This study was designed to determine the number of people with detectable antibodies to SARS-CoV-2 from two samples of healthy adults with and without a previous history of severe respiratory infection in the last 6 months of the study.

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.